Millstone Evans Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Millstone Evans Group's AMGN Position: Q2 2026 in Review
Millstone Evans Group increased its Amgen (AMGN) stake by 1.1% in Q2 2026, buying an estimated $2.4K and bringing the position to 673 shares worth $244K. The position accounts for 0.13% of the portfolio, ranked #122.
Millstone Evans Group first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Millstone Evans Group held 673 shares of Amgen worth $244K as of Q2 2026.
- Millstone Evans Group bought 7 Amgen shares in Q2 2026, an estimated $2.4K.
- Amgen made up 0.13% of Millstone Evans Group's portfolio in Q2 2026, its #122 holding.
- Millstone Evans Group first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.